Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). The purpose of this study is
to test whether Biphasic Insulin Aspart 70/30 twice a day with Metformin improves glycemic
control vs. once daily Insulin Glargine with Metformin in subjects with Type 2 Diabetes who
are inadequately controlled on basal insulin plus oral anti-diabetic therapy.